摘要 |
The invention relates to the use of a compound of the formula I, or a pharmaceutically acceptable salt thereof, for the manufacture of a medicament for use in modulating an immune or inflammatory response:
wherein:
Z = O or S;
n = 1-3;
R 3 = -CO 2 R 8 , -C(O)SR 8 , -C(O)NHR 8 , -C(S)OR 8 , -C(S)SR 8 , -C(S)NHR 8 , -C(NH)SR 8 or -C(NH)NHR 8 ,
wherein R 8 is -H or alkyl;
R 4 = -H, -CH 2 R 5 or -CH 2 CH 2 R 5 ,
wherein R 5 independently has one of the meanings of R 3 ;
B = -NR 2 -, -CH 2 NR 2 -, -CH 2 CH 2 NR 2 -, -CH 2 CHR 7 - or -CH 2 O-,
wherein R 2 is H or a C 1-3 alkyl, alkenyl or alkynyl group, and
R 7 is H or a C 1-3 alkyl or alkoxy group;
A =
wherein R 1 = -NH 2 or -OH,
C and D are each, independently, a 5- or 6-membered, substituted or unsubstituted, aromatic or non-aromatic ring which may also contain one or more heteroatoms, and C is connected to group B in any available position. |